Methylphenidate Extended-Release
NDC 62542-250, methylphenidate extended-release, tablet, orally disintegrating, from Neos Therapeutics, LP.
- Product NDC
- 62542-250
- Status
- Listed
- Labeler
- Neos Therapeutics, LP
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA205489
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/62542-250 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHYLPHENIDATE17.3 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62542-250-31 | 62542025031 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62542-250-31) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c2fec19b-6610-4ce0-8e60-f8218a11f62f
Use it
Look up 62542-250 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62542-250 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62542-250. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.